{"id":82465,"date":"2018-11-30T00:00:00","date_gmt":"2022-11-09T14:14:29","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/?post_type=eb_course&p=82465"},"modified":"2023-05-02T09:25:33","modified_gmt":"2023-05-02T13:25:33","slug":"making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/","title":{"rendered":"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease – Certificate of Completion"},"content":{"rendered":"

The advent of novel biologic medicines for the treatment of inflammatory bowel disease (IBD) has increased the availability of therapeutic options to induce and maintain remission in patients with this disease. They have become an important modality of treatment in IBD and the mainstay of therapy in patients with fistulising or perianal Crohn\u2019s disease (CD).<\/p>","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-82465","eb_course","type-eb_course","status-publish","hentry"],"acf":[],"yoast_head":"\nMaking the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"The advent of novel biologic medicines for the treatment of inflammatory bowel disease (IBD) has increased the availability of therapeutic options to induce and maintain remission in patients with this disease. They have become an important modality of treatment in IBD and the mainstay of therapy in patients with fistulising or perianal Crohn\u2019s disease (CD).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T13:25:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/\",\"name\":\"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"datePublished\":\"2022-11-09T14:14:29+00:00\",\"dateModified\":\"2023-05-02T13:25:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease – Certificate of Completion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/","og_locale":"fr_CA","og_type":"article","og_title":"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase","og_description":"The advent of novel biologic medicines for the treatment of inflammatory bowel disease (IBD) has increased the availability of therapeutic options to induce and maintain remission in patients with this disease. They have become an important modality of treatment in IBD and the mainstay of therapy in patients with fistulising or perianal Crohn\u2019s disease (CD).","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T13:25:33+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/","url":"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/","name":"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease - Certificate of Completion - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2022-11-09T14:14:29+00:00","dateModified":"2023-05-02T13:25:33+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/making-the-switch-biosimilar-infliximab-in-the-treatment-of-inflammatory-bowel-disease-certificate-of-completion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease – Certificate of Completion"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/82465","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=82465"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/82465\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=82465"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=82465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}